Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

NCT02249663 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1535

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: Azelastine hydrochloride and Fluticasone propionate
DRUG: Dymista™
OTHER: Placebo

Sponsor

Teva Pharmaceuticals USA